Protalix Biotherapeutics Inc (PLX)
Net Receivables
$16.50M
Quarterly · Period ending: · USD
PLX Net Receivables
Latest reported$16.50Mperiod ending
Latest reported$16.50Mperiod ending
PLX Quarterly Net Receivables ($0.00 → $16.50M)
Quarterly net receivables
High-resolution chart · PNG
PLX net receivables history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Receivables (USD) |
|---|---|
| 16,503,000 | |
| 2,939,000 | |
| 8,840,000 | |
| 14,425,000 | |
| 9,443,000 | |
| 4,675,000 | |
| 2,909,000 | |
| 2,195,000 | |
| 10,126,000 | |
| 3,759,000 | |
| 5,272,000 | |
| 8,935,000 | |
| 4,049,000 | |
| 1,304,000 | |
| 4,586,000 | |
| 8,651,000 | |
| 2,022,000 | |
| 5,908,000 | |
| 3,442,000 | |
| 5,561,000 | |
| 2,330,000 | |
| 4,599,000 | |
| 2,000,000 | |
| 3,146,000 | |
| 5,262,000 | |
| 8,876,000 | |
| 4,700,000 | |
| 8,716,000 | |
| 7,256,000 | |
| 8,565,000 | |
| 4,729,000 | |
| 4,894,000 | |
| 5,248,000 | |
| 4,756,000 | |
| 1,721,000 | |
| 7,292,000 | |
| 3,005,000 | |
| 2,737,000 | |
| 693,000 | |
| 2,096,000 | |
| 1,493,000 | |
| 0 | |
| 0 | |
| 4,573,000 | |
| 1,936,000 | |
| 1,816,000 | |
| 1,884,000 | |
| 1,992,000 | |
| 2,097,000 | |
| 1,735,000 | |
| 2,091,000 | |
| 2,053,000 | |
| 2,030,000 | |
| 1,698,000 | |
| 1,410,000 | |
| 0 | |
| 1,536,000 | |
| 815,000 | |
| 1,374,000 | |
| 0 | |
| 1,720,000 | |
| 0 | |
| 9,244,000 | |
| 8,943,000 | |
| 3,768,000 | |
| 3,625,000 | |
| 2,144,000 | |
| 2,684,000 | |
| 1,945,000 | |
| 2,390,000 | |
| 793,000 | |
| 2,913,000 | |
| 1,920,000 | |
| 2,096,000 | |
| 1,354,000 | |
| 1,698,000 | |
| 2,277,000 | |
| 2,244,000 | |
| 1,336,000 | |
| 0 | |
| 0 | |
| 0 | |
| 254,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |